Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
'Tangled' live-action movie casts Teagan Croft and Milo Manheim as Rapunzel and Flynn - 2Heat Wave Fuels Massive Wildfire In Australia
- 3Sustaining Public activity and Connections: Key Methodologies
- 4The most effective method to Settle on Informed Conclusions about Senior Insuranc.
- 515 Preposterous Cosplay Ensembles That Will Blow You Away
- Finding the Universe of Workmanship: Individual Encounters in Imagination
- She was moments away from giving birth. The hospital discharged her
- Lilly, Novo lock horns in India's obesity drug race
- Famous Kitchen Finishing Styles For 2024
- Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
- What did the gov’t approve for Israel’s 2026 state budget?
- First Alert: Light snow through this evening
- Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- 6 Monetary Arranging Administrations for Your Necessities
